Cancer patients treated with chemotherapy for almost every type of solid tumor were found to be at increased risk for developing therapy-related myelodysplastic syndrome or acute myeloid leukemia (MDS ...
CAR T cell therapy has revolutionized the treatment of many blood cancers, but has shown little success against solid tumors, which account for over 85% of all cancers. Columbia researchers have now ...
Enhertu (fam-trastuzumab deruxtecan-nxki) demonstrated activity across multiple types of solid cancers — including some that are notoriously difficult to treat— according to findings from the phase 2 ...